Trial intelligence / Profile preview

Teriparatide for Postoperative Hypocalcemia in Dialysis Patients (TeriCa)

NCT04750460Phase 3Completed

Sponsor
Saint Petersburg State University
Start
Mar 2021
Primary completion
Feb 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of teriparatide in hypocalcemia, sponsored by Saint Petersburg State University. Started Mar 2021; status: completed.

02

Drugs

teriparatide
03

Conditions

hypocalcemia

Beyond the preview

Go deeper on NCT04750460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04750460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call